Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation

NCT: NCT04835844 · COMPLETED

NCT IDNCT04835844
StatusCOMPLETED
Start Date2020-07-24
Completion2025-07-11

Brief Summary

The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.

Frequently Asked Questions

What is RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation?

RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation is a clinical trial registered under NCT04835844. Current status: COMPLETED.

What is the status of NCT04835844?

The current status of NCT04835844 (RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation) is: COMPLETED.

When did RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation start?

RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation started on 2020-07-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑